PTGS2 and neoplasm: Cumulatively, a substantial reduction of GSH levels (Fig. 5i) accompanied by the elevation of ROS, PTGS2 and LPO levels (Fig. 5j–l) were detected in tumor tissues following Gi-F-CAA treatment compared with that in PBS, Gi-F and Gi-F-SA treatment group.